Gastrointestinal intervention ameliorates high blood pressure through antagonizing overdrive of the sympathetic nerve in hypertensive patients and rats

Journal of the American Heart Association

Volumn 3, Issue 5, 2014, Pages

  Zhang, Hexuan ^a   Pu, Yunfei ^a   Chen, Jing ^a   Tong, Weidong ^a   Cui, Yuanting ^a   Sun, Fang ^a   Zheng, Zhou ^a   Li, Qiang ^a   Yang, Tao ^a   Meng, Changyuan ^a   Lu, Zongshi ^a   Li, Li ^a   Yan, Zhencheng ^a   Liu, Daoyan ^a   Zhu, Zhiming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric bypass surgery; Gastrointestinal intervention; Hypertension; Sympathetic nervous system

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOMETABOLIC RISK; CARDIOVASCULAR PARAMETERS; COLD STRESS; CONTROLLED STUDY; DIABETIC HYPERTENSION; DISEASE ASSOCIATION; ELECTROSTIMULATION; ENDOTHELIUM DEPENDENT FLOW MEDIATED DILATION; FEMALE; HEART RATE VARIABILITY; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE; NERVE STIMULATION; NERVOUS SYSTEM PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL SYMPATHETIC NERVOUS ACTIVITY; ROUX Y ANASTOMOSIS; SOLITARY TRACT NUCLEUS; SYMPATHETIC NERVE INHIBITION; VASOCONSTRICTION; WEIGHT REDUCTION; ADRENERGIC SYSTEM; ANIMAL; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; COLD SHOCK RESPONSE; COMPLICATION; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; DRUG EFFECTS; HEART RATE; INNERVATION; LAPAROSCOPY; MICROINJECTION; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PROCEDURES; SPONTANEOUSLY HYPERTENSIVE RAT; STOMACH BYPASS; TIME; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASODILATATION;

4 AMINOBUTYRIC ACID; BIOLOGICAL MARKER;

ADULT; ANIMALS; BIOMARKERS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; COLD-SHOCK RESPONSE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ENDOTHELIUM, VASCULAR; FEMALE; GAMMA-AMINOBUTYRIC ACID; GASTRIC BYPASS; HEART RATE; HUMANS; HYPERTENSION; LAPAROSCOPY; MALE; MICROINJECTIONS; MIDDLE AGED; OBESITY; RATS, INBRED SHR; SOLITARY NUCLEUS; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; TREATMENT OUTCOME; VASODILATION;

EID: 84939461337     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.000929     Document Type: Article

References (65)

1. Blessing WW. The Lower Brainstem and Bodily Homeostasis. New York, NY: Oxford University Press; 1997.
2. Loewy AD, Spyer KM. Central Regulation of Autonomic Functions. New York, NY: Oxford University Press; 1990.
3. Mancia G, Daffonchio A, Di Rienzo M, Ferrari A, Grassi G. Methods to quantify sympathetic cardiovascular influences. Eur Heart J. 1998;19:F7.
4. Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J. 2012;33:1058-1066.
5. Esler M, Lambert E, Schlaich M. Point: chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol. 2010;109:1996-1998.
6. Levick SP, Murray DB, Janicki JS, Brower GL. Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart. Hypertension. 2010;55:270-276.
7. Schiffrin EL. Vascular remodeling in hypertension mechanisms and treatment. Hypertension. 2012;59:367-374.
8. Wang J, Wang H, Luo W, Guo C, Wang J, Chen Y, Chang L, Eitzman DT. Leptin-induced endothelial dysfunction is mediated by sympathetic nervous system activity. J Am Heart Assoc. 2013;2:e000299 doi:10.1161/JAHA.113.000299.
9. Lohmeier TE, Iliescu R. Chronic lowering of blood pressure by carotid baroreflex activation mechanisms and potential for hypertension therapy. Hypertension. 2011;57:880-886.
10. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7:335-346.
11. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-1281.
12. Cummings DE. Metabolic surgery for type 2 diabetes. Nat Med. 2012;18:656.
13. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567-1576.
14. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery. JAMA. 2004;292:1724-1737.
15. Rodríguez A, Becerril S, Valentí V, Moncada R, Méndez-Giménez L, Ramírez B, Lancha A, Martín M, Burrell MA, Catalán V. Short-term effects of sleeve gastrectomy and caloric restriction on blood pressure in diet-induced obese rats. Obes Surg. 2012;22:1481-1490.
16. Arterburn D, Schauer DP, Wise RE, Gersin KS, Fischer DR, Selwyn CA Jr, Erisman A, Tsevat J. Change in predicted 10-year cardiovascular risk following laparoscopic roux-en-y gastric bypass surgery. Obes Surg. 2009;19:184-189.
17. Ahmed AR, Rickards G, Coniglio D, Xia Y, Johnson J, Boss T, O'Malley W. Laparoscopic roux-en-y gastric bypass and its early effect on blood pressure. Obes Surg. 2009;19:845-849.
18. Cowan GS, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg. 1998;22:987-992.
19. Hallersund P, Sjöström L, Olbers T, Lönroth H, Jacobson P, Wallenius V, Näslund I, Carlsson LM, Fändriks L. Gastric bypass surgery is followed by lowered blood pressure and increased diuresis-long term results from the Swedish Obese Subjects (SOS) study. PLoS One. 2012;7:e49696.
20. Sjöström L, Lindroos A-K, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.
21. Nguyen NT, Perez RV, Fleming N, Rivers R, Wolfe BM. Effect of prolonged pneumoperitoneum on intraoperative urine output during laparoscopic gastric bypass. J Am Coll Surg. 2002;195:476-483.
22. Romero F, Nicolau J, Flores L, Casamitjana R, Ibarzabal A, Lacy A, Vidal J. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-en-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc. 2012;26:2231-2239.
23. Wasmund SL, Owan T, Yanowitz FG, Adams TD, Hunt SC, Hamdan MH, Litwin SE. Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study. Heart Rhythm. 2011;8:84-90.
24. Curry TB, Somaraju M, Hines CN, Groenewald CB, Miles JM, Joyner MJ, Charkoudian N. Sympathetic support of energy expenditure and sympathetic nervous system activity after gastric bypass surgery. Obesity. 2013;21:480-485.
25. Alberti G, Zimmet P, Shaw J, Grundy SM. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: Int Diabetes Fed. 2005;366:1059-1602.
26. Bariatric Surgical in the Treatment of Patients with Type 2 Diabetes. A position statement from the Chinese Diabetes Society. China J Pract Surg. 2011;31:367-370.
27. Huang C-K, Shabbir A, Lo C-H, Tai C-M, Chen Y-S, Houng J-Y. Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obes Surg. 2011;21:1344-1349.
28. He H, Zhao Z, Chen J, Ni Y, Zhong J, Yan Z, Li Y, Liu D, Pletcher MJ, Zhu Z. Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial. J Hypertens. 2012;30:1430-1439.
29. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial arterya report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-265.
30. Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab. 2010;12:130-141.
31. Shin AC, Zheng H, Townsend RL, Sigalet DL, Berthoud H-R. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology. 2010;151:1588-1597.
32. Brown AR, Antle MC, Hu B, Teskey GC. High frequency stimulation of the subthalamic nucleus acutely rescues motor deficits and neocortical movement representations following 6-hydroxydopamine administration in rats. Exp Neurol. 2011;231:82-90.
33. Shechtman O, Fregly MJ, van Bergen P, Papanek PE. Prevention of coldinduced increase in blood pressure of rats by captopril. Hypertension. 1991;17:763-770.
34. Sun Z, Fregly MJ, Cade JR. Effect of renal denervation on elevation of blood pressure in cold-exposed rats. Can J Physiol Pharmacol. 1995;73:72-78.
35. Pleger ST, Remppis A, Heidt B, Völkers M, Chuprun JK, Kuhn M, Zhou R-H, Gao E, Szabo G, Weichenhan D. S100a1 gene therapy preserves in vivo cardiac function after myocardial infarction. Mol Ther. 2005;12:1120-1129.
36. Wang W-Z, Wang L-G, Gao L, Wang W. Contribution of AMPA/kainate receptors in the rostral ventrolateral medulla to the hypotensive and sympathoinhibitory effects of clonidine. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1232-R1238.
37. Wang P, Yan Z, Zhong J, Chen J, Ni Y, Li L, Ma L, Zhao Z, Liu D, Zhu Z. Transient receptor potential vanilloid 1 activation enhances gut glucagon-like peptide-1 secretion and improves glucose homeostasis. Diabetes. 2012;61:2155-2165.
38. Aceros H, Farah G, Cobos-Puc L, Stabile A, Noiseux N, Mukaddam-Daher S. Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt. Br J Pharmacol. 2011;164:946-957.
39. Fernstrom JD, Courcoulas AP, Houck PR, Fernstrom MH. Long-term changes in blood pressure in extremely obese patients who have undergone bariatric surgery. Arch Surg. 2006;141:276.
40. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237:751.
41. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-1585.
42. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12:453-466.
43. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393-411.
44. Li JV, Ashrafian H, Bueter M, Kinross J, Sands C, le Roux CW, Bloom SR, Darzi A, Athanasiou T, Marchesi JR. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut. 2011;60:1214-1223.
45. Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX, Xu G, Pu Y, Zhu Z, Xu A, Lam KS, Chen ZY, Ng CF, Yao X, Huang Y. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism. Hypertension. 2012;60:833-841.
46. Wang B, Zhong J, Lin H, Zhao Z, Yan Z, He H, Ni Y, Liu D, Zhu Z. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials. Diabetes Obes Metab. 2013;15:737-749.
47. Linz D, Wirth K, Linz W, Heuer HO, Frick W, Hofmeister A, Heinelt U, Arndt P, Schwahn U, Böhm M. Antihypertensive and laxative effects by pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut. Hypertension. 2012;60:1560-1567.
48. Wofford MR, Anderson DC, Brown CA, Jones DW, Miller ME, Hall JE. Antihypertensive effect of α-and ß-adrenergic blockade in obese and lean hypertensive subjects. Am J Hypertens. 2001;14:694-698.
49. Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des. 2004;10:3621-3637.
50. Cragg BG, Evans D. Some reflexes mediated by the afferent fibers of the abdominal vagus in the rabbit and cat. Exp Neurol. 1960;2:1-12.
51. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13:701-712.
52. Mul JD, Begg DP, Barrera JG, Li B, Matter EK, D'Alessio DA, Woods SC, Seeley RJ, Sandoval DA. High-fat diet changes the temporal profile of GLP-1 receptor-mediatedhypophagia in rats. Am J Physiol Regul Integr Comp Physiol. 2013;305:R68-R77.
53. Taubin H, Djahanguiri B, Landsberg L. Noradrenaline concentration and turnover in different regions of the gastrointestinal tract of the rat: an approach to the evaluation of sympathetic activity in the gut. Gut. 1972;13:790-795.
54. Gautron L, Zechner J, Aguirre V. Vagal innervation patterns following Roux-en-Y gastric bypass in the mouse. Int J Obes. 2013;37:1603-1607.
55. Berthoud H-R, Shin AC, Zheng H. Obes Surg and gut-brain communication. Physiol Behav. 2011;105:106-119.
56. Dietrich WD, Lowry OH, Loewy AD. The distribution of glutamate, GABA and aspartate in the nucleus tractus solitarius of the cat. Brain Res. 1982;237:254-260.
57. Izzo PN, Sykes RM, Spyer KM. Gamma-aminobutyric acid immunoreactive structures in the nucleus tractus solitarius: a light and electron microscopic study. Brain Res. 1992;591:69-78.
58. Potts JT, Paton JF, Mitchell JH, Garry MG, Kline G, Anguelov PT, Lee SM. Contraction-sensitive skeletal muscle afferents inhibit arterial baroreceptor signalling in the nucleus of the solitary tract: role of intrinsic GABA interneurons. Neuroscience. 2003;119:201-214.
59. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393-1401.
60. D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H. Impact of renal denervation on renal content of glut1, albuminuria and urinary tgf-ß1 in streptozotocin-induced diabetic rats. Auton Neurosci. 2003;104:88-94.
61. Witkowski A, Prejbisz A, Florczak E, Kazdziela J, Śliwiński P, Bieleń P, Michałowska I, Kabat M, Warchoł E, Januszewicz M. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58:559-565.
62. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertensionclinical perspective a pilot study. Circulation. 2011;123:1940-1946.
63. Katayama T, Sueta D, Kataoka K, Hasegawa Y, Koibuchi N, Toyama K, Uekawa K, MingJie M, Nakagawa T, Maeda M, Ogawa H, Kim-Mitsuyama S. Long-term renal denervation normalizes disrupted blood pressure circadian rhythm and ameliorates cardiovascular Injury in a rat model of metabolic syndrome. J Am Heart Assoc. 2013;2:e000197 doi: 10.1161/JAHA.113.000197.
64. Seravalle G, Colombo M, Perego P, Giardini V, Volpe M, Dell'Oro R, Mancia G, Grassi G. Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients. Hypertension. 2014;64:431-437.
65. Mark AL, Norris AW, Rahmouni K. Sympathetic inhibition after bariatric surgery. Hypertension. 2014;64:235-236.